Back to Search
Start Over
Global Dyslipidemia Drugs Market Set to Reach $30.98 Billion by 2034 with Statins Dominating and PCSK9 Inhibitors Showing Rapid Growth
- Source :
- Plus Company Updates. March 11, 2024
- Publication Year :
- 2024
-
Abstract
- DUBLIN: Research and Markets has issued the following news release: The 'Global Dyslipidemia Drugs Market by Drug Class, By Indication, by Distribution Channel, and By Region' report has been added [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.787023046